Cognizin Citicoline can help reduce Cocaine use.
Results of a randomized, double blind, placebo – controlled clinical trial showed that Cognizin citicoline was effective at reducing cocaine use, based on urine drug screens, in patients with bipolar disorder and cocaine dependence. The study included a total of 130 outpatients with bipolar I disorder and cocaine dependence, who received either Cognizin citicoline or placebo addon therapy for 12 weeks
In the study, placebo and citicoline grouds submitted to three weeking urine drug screens. Mood was assessed by the Inventory of Depressive Symptomatology – Self Report. Hamiltion Depression Rating Scale, and Young Mania Rating Scale.
The citicoline group saw no significant group differences in manic or depressive symptoms following supplementation. At the same time, Cognizin citicoline decreased cocaine use without impacting mood, meaning the efficacy of citicoline for reducing cocaine use not only hold promise as a treatment in this population, but could potentially hold true for other patients.